Kallab Martin

Kallab Martin, Vieboeck Isabella, Panahi Parsa, Mansouri Kaweh, Bolz Matthias, Huang Alex S et al.

Excimer laser trabeculostomy significantly improved aqueous humor outflow, even beyond the treatment site, suggesting potential for enhanced glaucoma treatment.

Huang Alex S, Garner Mary Anne, Clark Mark E, Rhodes Lindsay A, Kallab Martin, Zhang Hao F et al.

Cholinergic stimulation improved aqueous humor outflow in specific, low-flow regions of human eyes, suggesting potential for targeted glaucoma treatments.

Schuhmayer Anna C, Karl Nina A M, Pomberger Leon, Eidherr Markus, Khalil Haidar, Kallab Martin et al.

This study found Faricimab caused a faster reduction in retinal blood flow than Aflibercept, while both equally reduced choroidal flow. This suggests differing Tie2 receptor distribution, impacting anti-VEGF treatment effects.

Kallab Martin, Huang Alex S, Bolz Matthias, Strohmaier Clemens A

This review found AS-OCT/AS-OCTA shows promise for assessing glaucoma bleb function after surgery, but inconsistent study methods currently limit its routine clinical application.

Hinterberger Sarah, Schneider Sophie, Kallab Martin, Murauer Olivia, Reisinger Anna-Sophie, Bolz Matthias et al.

This real-world study found the Preserflo MicroShunt achieved 60.5% overall success at two years, significantly reducing IOP and medication, offering a viable surgical option for diverse glaucoma patients.

Schneider Sophie, Kallab Martin, Murauer Olivia, Reisinger Anna-Sophie, Strohmaier Susanne, Huang Alex S et al.

Early bleb vessel density measured by AS-OCTA after Preserflo Microshunt surgery predicts future surgical revisions, offering an objective biomarker for bleb failure risk.